Léčivé přípravky s obsahem účinné látky Alektinib

Economic Operator with Whom the Contract Has Been Concluded


Show detail
DetailS2026/00659/0007. 07. 2026ROCHE s.r.o.19 550 294,4017 455 620,0019 550 294,4017 455 620,00CZK

Published Documents


Show detail
DetailS2026/00659/00S2026_00659_00_KS_Alektinib_anonym.pdfSmlouva09. 07. 2026 11:25Dokument není zavirovaný

List of Participants


Show detail
DetailROCHE s.r.o.Praha 8-Karlín19 550 294,4017 455 620,00CZKYesYes

Written Report - Justification


Show detail
Justification for using other means of communication for submitting bids instead of electronic means
Justification for not dividing an above-threshold public procurement into lots
Justification for setting requirements for proving turnover in case of proceeding according to Article 78(3), if not stated in the tender documentation
DetailPředmět VZ rozdělení neumožňuje.Nebylo požadováno.